XML 16 R8.htm IDEA: XBRL DOCUMENT

LIQUIDITY	3 Months Ended
Mar. 31, 2022
LIQUIDITY
Liquidity	NOTE 2 – LIQUIDITY: At March 31, 2022 and December 31, 2021, the Company had cash and cash equivalents of approximately $481,685 and $497,135, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the three months ended March 31, 2022 and 2021, amounted to $22,073 and $24,342, respectively, and we had working capital of approximately $474,585 and $496,658 at March 31, 2022 and December 31, 2021, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.

LIQUIDITY

3 Months Ended

Mar. 31, 2022

NOTE 2 – LIQUIDITY:

At March 31, 2022 and December 31, 2021, the Company had cash and cash equivalents of approximately $481,685 and $497,135, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the three months ended March 31, 2022 and 2021, amounted to $22,073 and $24,342, respectively, and we had working capital of approximately $474,585 and $496,658 at March 31, 2022 and December 31, 2021, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.